Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Seroxat - API Insight, 2019-2021: Historical & Forecasted Sales, Emerging Therapies and Key Opportunities - ResearchAndMarkets.com

March 13, 2019

DUBLIN--(BUSINESS WIRE)--Mar 13, 2019--The “Seroxat - API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Seroxat - API Insight, 2019 provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Seroxat. The report also highlights the patent details of Seroxat.

Scope of the Report

  • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
  • Patent information around Seroxat in United States (US) and Europe (EU) has been highlighted
  • API manufacturers for Seroxat in United States, Europe, China and India
  • The report contains historical and forecasted sales for Seroxat till 2021
  • Enlists the market competition and emerging therapies in the space where Seroxat operates

Reasons to Buy

  • Evaluate the marketing status of Seroxat to exploit opportunities for generic Seroxat development opportunities
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Seroxat
  • API intelligence over Seroxat and gaining primary intelligence over Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth analysis of Seroxat’s performance

Topics Covered

1. Seroxat Overview

2. Seroxat Global Sales Assessment

  • Seroxat Historical Global Sales
  • Seroxat Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by Country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vh2xzt/seroxat_api?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190313005289/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Mental Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/13/2019 05:18 AM/DISC: 03/13/2019 05:18 AM


All contents © copyright 2019 The Associated Press. All rights reserved.